Talukder MEK - Search Results

1

Multi-modal neuroprotection of Argemone mexicana L. against Alzheimer's disease: In vitro and in silico study.

Talukder MEK, Akhter S, Ahammad F, Aktar A, Islam MS, Laboni AA, Afroze M, Khan M, Uddin MJ, Rahman MM. Talukder MEK, et al. Heliyon. 2024 Aug 30;10(17):e37178. doi: 10.1016/j.heliyon.2024.e37178. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39286063 Free PMC article.

2

Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD.

Bouback TA, Pokhrel S, Albeshri A, Aljohani AM, Samad A, Alam R, Hossen MS, Al-Ghamdi K, Talukder MEK, Ahammad F, Qadri I, Simal-Gandara J. Bouback TA, et al. Among authors: talukder mek. Molecules. 2021 Aug 17;26(16):4961. doi: 10.3390/molecules26164961. Molecules. 2021. PMID: 34443556 Free PMC article.

3

Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2.

Pokhrel S, Bouback TA, Samad A, Nur SM, Alam R, Abdullah-Al-Mamun M, Nain Z, Imon RR, Talukder MEK, Tareq MMI, Hossen MS, Karpiński TM, Ahammad F, Qadri I, Rahman MS. Pokhrel S, et al. Among authors: talukder mek. Int J Biol Macromol. 2021 Nov 30;191:1114-1125. doi: 10.1016/j.ijbiomac.2021.09.146. Epub 2021 Sep 27. Int J Biol Macromol. 2021. PMID: 34592225 Free PMC article.

4

In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever.

Alam R, Samad A, Ahammad F, Nur SM, Alsaiari AA, Imon RR, Talukder MEK, Nain Z, Rahman MM, Mohammad F, Karpiński TM. Alam R, et al. Among authors: talukder mek. BMC Med. 2023 Feb 1;21(1):36. doi: 10.1186/s12916-023-02750-9. BMC Med. 2023. PMID: 36726141 Free PMC article.

5

Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease.

Olagunju AS, Ahammad F, Alagbe AA, Otenaike TA, Teibo JO, Mohammad F, Alsaiari AA, Omotoso O, Talukder MEK. Olagunju AS, et al. Among authors: talukder mek. Heliyon. 2023 Mar 11;9(3):e14387. doi: 10.1016/j.heliyon.2023.e14387. eCollection 2023 Mar. Heliyon. 2023. PMID: 36942213 Free PMC article. Review.

6

Computational formulation of a multiepitope vaccine unveils an exceptional prophylactic candidate against Merkel cell polyomavirus.

Imon RR, Samad A, Alam R, Alsaiari AA, Talukder MEK, Almehmadi M, Ahammad F, Mohammad F. Imon RR, et al. Among authors: talukder mek. Front Immunol. 2023 Jun 27;14:1160260. doi: 10.3389/fimmu.2023.1160260. eCollection 2023. Front Immunol. 2023. PMID: 37441076 Free PMC article.

7

Biological and clinical significance of the glypican-3 gene in human lung adenocarcinoma: An in silico analysis.

Imon RR, Aktar S, Morshed N, Nur SM, Mahtarin R, Rahman FA, Talukder MEK, Alam R, Karpiński TM, Ahammad F, Zamzami MA, Tan SC. Imon RR, et al. Among authors: talukder mek. Medicine (Baltimore). 2023 Nov 10;102(45):e35347. doi: 10.1097/MD.0000000000035347. Medicine (Baltimore). 2023. PMID: 37960765 Free PMC article.

8

Unveiling therapeutic efficacy of extract and multi-targeting phytocompounds from Christella dentata (Forssk.) Brownsey & Jermy against multidrug-resistant Pseudomonas aeruginosa.

Rahman MM, Islam MR, Talukder MEK, Atif MF, Alam R, Uddin AFMS, Anis-Ul-Haque KM, Islam MS, Uddn MJ, Akhter S. Rahman MM, et al. Among authors: talukder mek. RSC Adv. 2024 Feb 16;14(9):6096-6111. doi: 10.1039/d3ra08367e. eCollection 2024 Feb 14. RSC Adv. 2024. PMID: 38370460 Free PMC article.

9

Neuropharmacological assessment and identification of possible lead compound (apomorphine) from Hygrophila spinosa through in-vivo and in-silico approaches.

Uddin MJ, Niloy SI, Aktaruzzaman M, Talukder MEK, Rahman MM, Imon RR, Uddin AFMS, Amin MZ. Uddin MJ, et al. Among authors: talukder mek. J Biomol Struct Dyn. 2024 Feb 22:1-16. doi: 10.1080/07391102.2024.2317974. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38385482

10

Cheminformatics-based identification of phosphorylated RET tyrosine kinase inhibitors for human cancer.

Talukder MEK, Aktaruzzaman M, Siddiquee NH, Islam S, Wani TA, Alkahtani HM, Zargar S, Raihan MO, Rahman MM, Pokhrel S, Ahammad F. Talukder MEK, et al. Front Chem. 2024 Jul 17;12:1407331. doi: 10.3389/fchem.2024.1407331. eCollection 2024. Front Chem. 2024. PMID: 39086985 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters